Kinexa Tablet 15 mg contains Rivaroxaban, a modern oral anticoagulant used for the prevention and treatment of blood clot–related disorders. Rivaroxaban belongs to the class of direct oral anticoagulants (DOACs) and works by selectively inhibiting Factor Xa, an essential enzyme in the blood coagulation pathway. By reducing clot formation, Kinexa Tablet helps prevent serious complications such as stroke, deep vein thrombosis, and pulmonary embolism.

The 15 mg strength is commonly prescribed in specific clinical situations, including the initial treatment phase of venous thromboembolism or in patients who require dose adjustment due to renal function or other clinical considerations, as determined by a physician.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Rivaroxaban directly inhibits Factor Xa, which plays a central role in the coagulation cascade. Inhibition of this enzyme leads to:

• Reduced conversion of prothrombin to thrombin

• Decreased formation of fibrin clots

• Lower risk of abnormal blood clot development

This targeted mechanism provides effective and predictable anticoagulation with a lower need for routine laboratory monitoring compared to traditional anticoagulants.

Therapeutic Indications

Kinexa Tablet 15 mg is indicated for:

• Treatment of deep vein thrombosis (DVT)

• Treatment of pulmonary embolism (PE)

• Prevention of recurrent DVT and PE following initial therapy

• Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, particularly in those requiring dose adjustment

• Short- or long-term anticoagulation as advised by a healthcare professional

The exact indication and duration of therapy depend on the patient’s condition, risk factors, and clinical response.

Dosage and Administration

• Kinexa Tablet should be taken strictly according to the physician’s prescription.

• The commonly prescribed dose is 15 mg once or twice daily, depending on the indication and phase of treatment.

• Tablets should preferably be taken with food to enhance absorption.

• Swallow the tablet whole with water; do not crush or chew.

Maintaining consistent daily dosing is important to ensure continuous anticoagulant protection.

Safety Information and Precautions

• Kinexa Tablet must be used under medical supervision.

• Use with caution in patients with kidney or liver impairment.

• Not recommended in patients with active bleeding or known bleeding disorders.

• Concomitant use with other anticoagulants, antiplatelet agents, or certain medicines may increase bleeding risk.

• Patients should inform their healthcare provider about all medicines, supplements, or herbal products they are taking.

Sudden discontinuation without medical advice may increase the risk of thrombotic events.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Bleeding is the most significant potential side effect of Rivaroxaban. Commonly reported effects may include:

• Easy bruising

• Nosebleeds

• Bleeding gums

• Gastrointestinal discomfort

Any unusual, prolonged, or severe bleeding should be reported to a healthcare professional immediately.

Storage Instructions

• Store below 30°C in a dry place.

• Protect from moisture and direct sunlight.

• Keep out of reach of children.

Key Benefits of Kinexa Tablet 15 mg

• Effective prevention and treatment of blood clots

• Targeted Factor Xa inhibition

• Convenient oral dosing

• Reduces the risk of stroke and thromboembolic complications

Kinexa Tablet 15 mg (Rivaroxaban) offers a reliable and evidence-based anticoagulation option, helping patients manage clot-related conditions safely and effectively under proper medical guidance.